Abstract
Activation of the immune system during various medical conditions produces neural, neuroendocrine, and behavioral effects. The psychological and physiological effects of immune activation resemble many characteristics of depression. The essential features of depression are depressed mood and loss of interest or pleasure in all, or almost all activities (anhedonia). Several associated symptoms are also present, including, appetite disturbance, change in body weight, sleep disturbance, psychomotor disturbance, fatigue, loss of energy, and difficulty in thinking or concentrating (DSM-IV, 1994). Depression is also characterized by specific alterations in the functioning of neurochemical and neuroendocrine systems, including monoaminergic systems and the hypothalamic-pituitary-adrenal (HPA) axis (Brown, Steinberg, & van Praag, 1994; Holsboer, 1995). Most of these psychological and neuroendocrine symptoms appear both in humans and animals during diseases that involve immune activation. Based on these findings, and on several additional lines of evidence that will be presented below, we have recently argued that immune activation is involved in the etiology and symptomatology of depression associated with various medical conditions (Yirmiya, 1997).
Keywords
- Human Immunodeficiency Virus
- Multiple Sclerosis
- Depressive Symptom
- Systemic Lupus Erythematosus
- Depressed Patient
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.
Chapter PDF
References
Abbey, S. E. & Garfinkel, P. E. (1991). Chronic fatigue syndrome and depression: Cause, effect or covariate. Reviews of Infectious Diseases, 13, S73–83.
Abramowitz, E. S., Baker, A. H., & Fleischer, S. F. (1982). Onset of depressive psychiatric crises and the menstrual cycle. American Journal of Psychiatry, 139(4), 475–478.
Adler, N. E., Boyce, T., Chesney, M. A., Cohen, S., Folkman, S., Khan, R. L., & Syme, S. L. (1994). Socioeconomic status and health. American Psychologist, 49(1), 15–24.
Albrecht, J., Helderman, J. H., Schlesser, M. A., & Rush, A. J. (1985). A controlled study of cellular immune function in affective disorders before and during somatic therapy. Psychiatry Research, 15, 185–193.
Anderson, N. B. & Armstead, C. A. (1995). Toward understanding the association of socioeconomic status and health: A new challenge for the biopsychosocial approach. Psychosomatic Medicine, 57, 213–225.
Anisman, H., Kokkinidis, L., & Merali, A. (1996). Interleukin-2 decreases accumbal dopamine efflux and responding for rewarding lateral hypothalamic stimulation. Brain Research, 731, 1–11.
Anisman, H., Kokkinidis, L., Borowski, T., & Merali, A. (1998). Differential effects of interleukin (IL)-l, IL-2, and IL-6 on responding for rewarding lateral hypothalamic stimulation. Brain Research, 779, 177–187.
Arenzana-Seisdedos, F. & Virelizer, J. L. (1983). Interferons as macrophage-activating factors. II. Enhanced secretion of interleukin-1 by lipopolysaccharide-stimulated human monocytes. European Journal of Immunology, 13, 437–440.
Arvin, B., Neville, L. F., Barone, F. C, & Feuerstein, G. Z. (1996). The role of inflammation and cytokines in brain injury. Neuroscience and Biobehavioral Reviews, 20, 445–452.
Aubert, A., Vega, G, Dantzer, R., & Goodall, G. (1995). Pyrogens specifically disrupt the acquisition of a task involving cognitive processing in the rat. Brain Behavior and Immunity, 9, 129–148.
Aubert, A. & Dantzer, R. (1998). Effects of lipopolysaccharide on taste reactivity in rats. Neuroim-munomodulation, 5, 3.
Audus, K. L. & Gordon, M. A. (1982). Tricyclic antidepressant effects on the murine lymphocyte mitogen response. Journal of Immunopharmacology, 4, 13–27.
Avitsur, R., Pollak, Y., & Yirmiya, R. (1997). Different receptor mechanisms mediate the effects of endotoxin and interleukin-1 on female sexual behavior. Brain Research, 773, 149–161.
Avitsur, R., Cohen, E., & Yirmiya, R. (1998). Effects of interleukin-1 on sexual attractivity in a model of sickness behavior. Physiology and Behavior, 63, 25–30.
Ayuso, J. L. (1994). Use of psychotropic drugs in patients with HIV infection. Drugs, 47(4), 599–610.
Badia-Elder, N., Kiefer, S. W., & Dess, N. K. (1996). Taste reactivity in rats selectively bred for high vs. low saccharin consumption. Physiology and Behavior, 59, 749–755.
Barden, N., Reul, J. M. H. M., & Holsboer, F. (1995). Do antidepressants stabilize mood through actions on the hypothalamic-pituitary-adrenocortical system? Trends in Neurosciences, 18, 6–11.
Bauer, J., Hohagen, F., Gimmel, E., Bruns, F., Lis, S., Krieger, S., Ambach, W., Guthmann, A., Grunze, H., Fritsch-Montero, R., Weissbach, A., Ganter, U., Frommnerger, U., Riemann, D., & Berger, M. (1995). Induction of cytokines synthesis and fever suppresses REM sleep and improves mood in patients with major depression. Biological Psychiatry, 38, 611–621.
Beers, D. R., Henkel, J. S., Kesner, R. P., & Stroop, W. G. (1995). Spatial recognition memory deficits without notable CNS pathology in rats following herpes simplex encephalitis. Journal of the Neurological Sciences, 131, 119–127.
Besedovsky, H. O. & Del-Rey, A. (1996). Immune-neuro-endocrine interactions: facts and hypotheses. Endocrine Reviews, 17, 64–102.
Bianchi, M., Sacerdote, P., & Panerai, A. E. (1994a). Fluoxetin reduces inflammatory edema in the rat: Involvement of the pituitary-adrenal axis. European Journal of Pharmacology, 263, 81–84.
Bianchi, M., Sacerdote, P., & Panerai, A. E. (1994b). Chlomipramine differentially affects inflammatory edema and pain in the rat. Pharmacology, Biochemistry, and Behavior, 4, 1037–1040.
Bianchi, M., Rossoni, G., Sacerdote, P., Panerai, A. E., & Berti, F. (1995). Effects of clomipramine and fluoxetin on subcutaneous carrageenin-induced inflammation in the rat. Inflammation Research, 44, 466–469.
Bluthe, R. M., Dantzer, R., & Kelley, K.W. (1991). Interleukin-1 mediates behavioral but not metabolic effects of tumor necrosis factor alpha in mice. European Journal of Pharmacology, 209, 281–283.
Bluthe, R. M., Crestani, F., Kelley, K. W., & Dantzer, R. (1992). Mechanisms of the behavioral effects of interleukin 1. Role of prostaglandins and CRF. Annals of The New York Academy of Sciences, 650, 268–275.
Bluthe, R. M., Dantzer, R., & Kelley, K. W. (1997). Central mediation of the effects of interleukin-1 on social exploration and body weight in mice. Psychoneuroendocrinology, 22, 1–11.
Bode, L., Zimmerman, W., Ferszt, R., Steinbach, F., & Ludwig, H. (1995). Borna disease virus genome transcribed and expressed in psychiatric patients. Nature Medicine, 1, 232–236.
Bode, L., Durrwald, R., Rantam, F. A., Ferszt, R., & Ludwig, H. (1996). First isolation of infectious human Borna disease virus from patients with mood disorders. Molecular Psychiatry, 1, 200–212.
Borowski, T., Kokkinidis, L., Merali, A., & Anisman, H. (1997). Behavioral and central monoamine alterations induced by interleukin-1, interleukin-6, and lipopolysaccharide. Society for Neuroscience Abstracts, 23, 1508.
Brady, L. S., Whitfield, H. J., Fox, R. J., Gold, P. W., & Herkenham, M. (1991). Long-term antidepressant administration alters corticotropin-releasing hormone, tyrosine hydroxylase, and mineralocorticoid receptor gene expression in rat brain. Journal of Clinical Investigation, 87, 831–837.
Brady, L. S., Gold, P. W., Herkenham, M., Lynn, A. B., & Whitfield, H. J. (1992). The antidepressants fluoxetine, idazoxan, and phenelzine alter corticotropin-releasing hormone and tyrosine hydroxylase mRNA levels in rat brain: therapeutic implications. Brain Research, 572, 117–125.
Breuille, D., Farge, M. C, Rose, F., Arnel, M., Attaix, D., & Obled, C. (1993). Pentoxifylline decreases body weight loss and muscle protein wasting characteristics of sepsis. American Journal of Physiology, 265, E660–E666.
Brown, S. L., Steinberg, R. L., & van Praag, H. M. (1994). The pathogenesis of depression: reconsideration of neurotransmitter data. In J. A. Den Boer & J. M. Sitsen (Eds.), Handbook of Depression and Anxiety: A Biological Approach (pp. 529–542). New York: Marcel Dekker, Inc.
Bruce, M. L., Takeuchi, D. T., & Leaf, P. J. (1991). Poverty and psychiatric status. Archives of General Psychiatry, 48, 470–474.
Buchwald, D. & Komaroff, A. L. (1991). Review of laboratory findings for patients with chronic fatigue syndrome. Reviews of Infectious Diseases, 13, 12–18.
Burnet, P. W. J., Michelson, D., Smith, M. A., Gold, P. W., & Sternberg, E. M. (1994). The effect of chronic imipramine administration on the densities of 5-HT1A and 5-HT2 receptors and the abundances of 5-HT receptor and transporter mRNA in the cortex, hippocampus, and dorsal raphe of three strains of rat. Brain Research, 638, 311–324.
Cannon, J. G. & Dinarello, C. A. (1985). Increased plasma interleukin-1 activity in woman after ovulation. Science, 227, 1247–1249.
Cappel, R., Gregoire, E., Thiry, L., & Sprecher, S. (1978). Antibody and cell-mediated immunity to herpes simplex virus in psychotic depression. Journal of Clinical Psychiatry, 39, 266–268.
Carroll, B. J., Martin, F. I. R., & Davies, B. (1968). Resistance to suppression by dexamethasone of plasma 11-hydroxycorticosterone levels in severe depressive illness. British Medical Journal, 3, 285–287.
Carroll, B. J., Curtis, G. C, & Mendels, J. (1976). Neuroendocrine regulation in depression. I. Limbic system adrenocortical dysfunction. Archives of General Psychiatry, 33, 1039–1044.
Cavallo, M. G., Pozzini, P., & Thorpe, R. (1993). Cytokines and autoimmunity. Clinical and Experimental Immunology, 96, 1–7.
Chochinov, H. M., Wilson, K. G., Enns, M., & Lander, S. (1994). Prevalence of depression in the terminally ill: Effects of diagnostic criteria and symptom threshold judgments. American Journal of Psychiatry, 4, 537–540.
Cleare, A. J., Bearn, J., Allain, T., McGregor, A., Wessely, S., Murray, R. M., & O’Keane, V. (1995). Contrasting neuroendocrine responses in depression and chronic fatigue syndrome. Journal of Affective Disorders, 34, 283–289.
Cohen, S. (1995). Psychological stress and susceptibility to upper respiratory infections. American Journal of Respiratory and Critical Care Medicine 152, 53–58.
Connor, T. J. & Leonard, B. E. (1998). Depression, stress and immunological activation: the role of cytokines in depressive disorders. Life Sciences, 62, 583–606.
Cox, S. M., King, M. R., Casey, M. L., & Macdonald, P. C. (1993). Interleukin-lβ,-lα, and-6 and prostaglandins in vaginal cervical fluids of pregnant women before and during labor. Journal of Clinical Endocrinology and Metabolism, 77, 805–815.
Cunningham, A. J., Murray, C. A., O’Neill, L. A. J., Lynch, M. A., & O’Connor, J. J. (1996). Interleukin-lβ (IL-lβ) and tumour necrosis factor (TNF) inhibit long-term potentiation in the rat dentate gyrus in vitro. Neuroscience Letters, 203, 17–20.
Dantzer, R., Bluthe, R. M., Aubert, A., Goodall, G., Bret-Dibat, J. L., Kent, S., Goujon, E., Laye, S., Parnet, P., & Kelley, K. W. (1996). Cytokine actions on behavior. In N. J. Rothwell (Ed.), Cytokines in the nervous system (pp. 117–144). New York: R. G. Landes Company and Chapman & Hall.
Day, H. E. W. & Akil, H. (1996). Differential pattern of c-fos mRNA in rat brain following central and systemic administration of interleukin-1 beta: Implications for mechanisms of action. Neuroendocrinology, 63, 207–218.
Denburg, S. D., Carbotte, R. M., & Denburg, J. A. (1997). Psychological aspects of systemic lupus erythematosus: Cognitive Function, mood, and self-report. Journal of Rheumatology, 24, 998–1003.
Dess, N. K. (1993). Saccharin’s aversive taste in rats: Evidence and implications. Neuroscience and Biobehavioral Reviews, 17, 359–372.
Dinarello, C. A. & Wolff, S. M. (1993). The role of interleukin-1 in disease. New England Journal of Medicine, 328, 106–113.
Dohrenwend, B. P. (1973). Social status and stressful life events. Journal of Personality and Social Psychology, 28, 225–235.
DSM-IV, Diagnostic and Statistical Manual of Mental Disorders Fourth Edition. (1994). Washington, DC: American Psychiatric Association.
Dunbar, P. R., Hill, J., Neale, T. J., & Mellsop, G. W. (1992). Neopterin measurement provides evidence of altered cell-mediated immunity in patients with depression, but not with schizophrenia. Psychological Medicine, 22, 1051–1057.
Dunn, A. J. & Welch, J. (1991). Stress-and endotoxin-induced increases in brain tryptophan and serotonin metabolism depend on sympathetic nervous system activity. Journal of Neurochemistry, 57, 1615–1622.
Dunn, A. J. & Wang, J. (1995). Cytokine effects on CNS biogenic amines. Neuroimmunomodulation, 2, 319–328.
Dunn, A. J., Chapman, Y., & Antoon, M. (1993). Endotoxin-induced behavioral changes of mice in the multicompartment chamber are distinct from those of interleukin-1. Neuroscience Research Communications, 10, 63–69.
Eisen, J. N., Irwin, J., Quay, J., & Livnat, S. (1989). The effect of antidepressants on immune function in mice. Biological Psychiatry, 26, 805–817.
Fent, K. & Zbinden, G. (1987). Toxicity of interferon and interleukin. Trends in Pharmacological Sciences, 8, 101–105.
Foley, F. W, Traugott, U, LaRocca, N. G, Smith, C. R., Perlman, K. R., Caruso, L. S., & Scheinberg, L. C. (1992). A prospective study of depression and immune dysregulation in multiple sclerosis. Archives of Neurology, 49, 238–244.
Gibertini, M. (1996). IL-1 beta impairs relational but not procedural rodent learning in a water maze task. Advances in Experimental Medicine and Biology, 402, 207–217.
Gibertini, M., Newton, C, Friedman, H., & Klein, T. W. (1995). Spatial learning impairment in mice with legionella pneumophila or administered exogenous interleukin-1-beta. Brain, Behavior, and Immunity, 9, 113–128.
Gold, P. W, Chrousos, G, Kellner, G, Post, R., Roy, A., Auerginos, P., Schulte, H., Oldfield, E., & Loriaux, D. L. (1984). Psychiatric implications of basic and clinical studies with corticotropin releasing factor. American Journal of Psychiatry, 141, 619–627.
Gottfries, C. G. (1997). Recognition and management of depression in the elderly. International Clinical Psychopharmacology, 12(7), S31–S36.
Goujon, E., Parnet, P., Laye, S., Combe, C, Kelley, K. W, & Dantzer, R. (1995). Stress downregulates lipopolysaccharide-induced expression of proinflammatory cytokines in the spleen, pituitary, and brain of mice. Brain, Behavior, and Immunity, 9, 292–303.
Granger, D. A., Hood, K. E., Ikeda, S. C, Reed, C. L., Jones, B. C, & Block, M. L. (1997). Effects of peripheral immune activation on social behavior and adrenocortical activity in aggressive mice: genotype environment interactions. Aggressive Behavior, 23, 93–105.
Greenwood, R. (1987). Residual mental disorders after herpesvirus infections. In E. Kurstak, Z. J. Lipowski, & P. V. Morozov (Eds.), Viruses, Immunity, and Mental Disorders (pp. 65–80). New York: Plenum.
Grill, J. J. & Norgren, R. (1978). The taste reactivity test. II. Mimetic responses to gustatory stimuli in chronic thalamic and chronic decerebrate rats. Brain Research, 143, 281–297.
Grossman, C. J. (1985). Interactions between the gonadal steroids and the immune system. Science, 227, 257–261.
Hall, S. & Smith, A. P. (1996a). Investigating the effects and aftereffects of naturally occurring upper respiratory tract illnesses on mood and performance. Physiology and Behavior, 59, 569–577.
Hall, S. & Smith, A. P. (1996b). Behavioral effects of infectious mononucleosis. Neuropsychobiology, 33, 202–209.
Hart, B. (1988). Biological basis of the behavior of sick animals. Neuroscience and Biobehavioral Reviews, 12, 123–37.
Hendler, N. (1987). Infectious mononucleosis and psychiatric disorders. In E. Kurstak, Z. J. Lipowski, & P. V. Morozov (Eds.), Viruses, Immunity, and Mental Disorders (pp. 81–94). New York: Plenum.
Herbert, T. B. & Cohen, S. (1993). Depression and immunity: A meta-analytic review. Psychological Bulletin, 3, 472–486.
Heyser, C. X, Masliah, E., Samimi, A., Campbell, I. L., & Gold, L. H. (1997). Progressive decline in avoidance learning paralleled by inflammatory neurodegeneration in transgenic mice expressing interleukin-6 in the brain. Proceedings of the National Academy of Sciences of the United States of America, 94, 1500–1505.
Hickie, I. & Lloyd, A. (1995). Are cytokines associated with neuropsychiatric syndromes in humans? International Journal of Immunopharmacology, 17, 677–683.
Holsboer, F. (1995). Neuroendocrinology of mood disorders. In F. E. Bloom & D. J. Kupfer (Eds.), Psychopharmacology: The Fourth Generation of Progress (pp. 957–969). New York: Raven Press.
Holsboer, F. & Barden, N. (1996). Antidepressants and hypothalamic-pituitary-adrenocortical regulation. Endocrine Reviews, 17, 187–205.
Holsboer, F., Liebel, R., & Hofschuster, E. (1982). Repeated dexamethasone test during depressive illness: normalization of test result compared with clinical improvement. Journal of Affective Disorders, 4, 93–101.
Hutchinson, G. A., Nehall, J. E., & Simeon, D. T. (1996). Psychiatric disorders in systemic lupus erythemato-sus. West Indian Medical Journal, 45, 48–50.
Isometsa, E.T., Aro, H. M., Henriksson, M. M., Heikkinen, M. E., & Lonnqvist, J. K. (1994). Suicide and major depression in different treatment settings. Journal of Clinical Psychiatry, 55, 523–527.
Joffe, R. T., Lippert, G. P., Gray, T. A., Sawa, G., & Horvath, A. (1987). Mood disorder and multiple sclerosis. Archives of Neurology, 44, 376–378.
Johnson, R. W., Propes, M. J., & Shavit, Y. (1996). Corticosterone modulates the behavioral and metabolic effects of lipopolysaccharide. American Journal of Physiology, 270, R192–R198.
Katon, W. & Sullivan, M. D. (1990). Depression and chronic medical illness. Journal of Clinical Psychiatry, 51, 3–11.
Katsuki, H., Nakai, S., Hirai, Y, Akaji, K., Kiso, Y, & Satoh, M. (1990). Interleukin-lβ inhibits long-term potentiation in the CA3 region of mouse hippocampal slices. European Journal of Pharmacology, 191, 323–326.
Kavaliers, M., Colwell, D. D., & Galea, L. A. M. (1995). Parasitic infection impairs spatial learning in mice. Animal Behaviour, 50, 223–229.
Kent, S., Bluthe, R. M., Kelley, K. W., & Dantzer, R. (1992a). Sickness behavior as a new target for drug development. Trends in Pharmacological Sciences, 13, 24–28.
Kent, S., Bluthe, R. M., Dantzer, R., Hardwick, A. J., Kelley, K. W., Rothwell, N. X, & Vannice, X L. (1992b). Different receptor mechanisms mediate the pyrogenic and behavioral effects of interleukin-1. Proceedings of the National Academy of Sciences of the United States of America, 89, 9117–9120.
Kiecolt-Glaser, J. K. & Glaser, R. (1991). Stress and immune function in humans. In R. Ader, D. L. Feiten, & N. Cohen (Eds.), Psychoneroimmunology (pp. 849–867). San Diego: Academic Press.
Klonoff, D. C. (1992). Chronic fatigue syndrome. Clinical infectious diseases, 15, 812–823.
Komaroff, A. L. & Buchwald, D. S. (1991). Symptoms and signs of chronic fatigue syndrome. Reviews of Infectious Diseases, 13, 8–11.
Komaroff, A. L. & Buchwald, D. S. (1998). Chronic fatigue syndrome: an update. Annual Review of Medicine, 49, 1–13.
Komaroff, A. L., Fagioli, L. R., Geiger, A. M., Doolittle, T. H., Lee, X, Kornish, X, Gleit, M. A., & Guerriero, R. T. (1996). An examination of the working case definition of chronic fatigue syndrome. American Journal of Medicine, 100, 56–64.
Kozak, W., Poli, V., Soszynski, D., Conn, C. A., Leon, L. R., & Kluger, M. (1996). Sickness behavior in mice deficient in interleukin-6 during turpentine abscess and influenza pneumonitis. American Journal of Physiology, 272, R621–R630.
Kozak, W., Soszynski, D., Rudolph, K., Conn, C. A., & Kluger, M. (1997). Dietary n-3 fatty acids differentially affect sickness behavior in mice during local and systemic inflammation. American Journal of Physiology, 272, R1298–R1307.
Krueger, J. M. & Majde, J. A. (1994). Microbial products and cytokines in sleep and fever regulation. Critical Reviews in Immunology, 14, 355–379.
Krueger, J. M., Takahashi, S., Kapas, L., Bredow, S., Roky, R., Fang, J., Floyd, R., Renegar, K. B., Guha-Thakurta, N., Novitsky, S., & Obal, F. (1995). Cytokines in sleep regulation. Advances in Neuroimmunology, 5, 171–188.
Kubera, M., Symbirtsev, A., Basta-Kaim, A., Borycz, J., Roman, A., Papp, M., & Claesson, M. (1996). Effect of chronic treatment with imipramine on interleukin-1 and interleukin-2 production by splenocytes obtained from rats subjected to chronic mild stress model of depression. Polish Journal of Pharmacology, 48, 503–506.
Laghrissi-Thode, F., Pollock, B. G., Szanto, K., & Reynolds, C. F. (1996). Depression and suicide in medically ill patients. Current Opinion in Psychiatry, 9, 137–140.
Landmann, R., Schaub, B., Link, S., & Wacker, H. R. (1997). Unaltered monocyte function in patients with major depression before and after three months of antidepressive therapy. Biological Psychiatry, 41, 675–681.
Laruelle, M., Seghers, A., Goffinet, S., Bouchez, S., & Legros, J. J. (1990). Plasmatic vasopressin neurophysin in depression: Basic levels and relations with HPA axis. Biological Psychiatry, 27, 1249–1263.
Lauritzen, L., Bjerg Bendsen, B., Vilmar, T., Bjerg Bendsen, E., Lunde, M., & Bech, P. (1994). Post-stroke depression: combined treatment with imipramine or desipramine and mianserin. Psychopharmacology, 114, 119–122.
Leonard, B. E. (1994). Effect of antidepressants on specific neurotransmitters: Are such effects relevant to the therapeutic actions? In J. A. den Boer & J. M. Siten (Eds.), Handbook of depression and anxiety: A biological approach (pp. 379–404). New York: Marcel Dekker, Inc.
Levenson, J. L. & Fallon, H. J. (1993). Fluoxetine treatment of depression caused by interferon-alpha. American Journal of Gastroenterology, 88(5), 760–761.
Li, Q., Levy, A. D., Cabrera, T. M, Brownfield, M. S., Battaglia, G., & Van de Kar, L. D. (1993). Long-term fluoxetine, but not desipramine, inhibits the ACTH and oxytocin responses to the 5-HT 1A agonist, 8-OH-DPAT, in male rats. Brain Research, 630, 148–156.
Licinio, J., Kling, M. A., & Hauser, P. (1998). Cytokines and brain function: relevance to interferon-alpha-induced mood and cognitive changes. Seminars in Oncology, 25(1), 30–38.
Lieb, J. & Karmali, R. (1983). Elevated levels of prostaglandin E2 and thromboxane B2 in depression. Prostaglandins and Leukotrienes in Medicine, 10, 361–368.
Lim, L., Ron, M. A., Ormerod, I. E., David, J., Miller, D. H., Logsdail, S. J., Walport, M. J., & Harding, A. E. (1988). Psychiatric and neurological manifestations in systemic lupus erythematosus. Quarterly Journal of Medicine, 66, 27–38.
Linkowski, P., Mendlewicz, 1, Leclercq, R., Brasseur, M., Hubain, P., Goldstein, J., Copinschi, G., & van Cauter, E. (1985). The 24-hr profile of adrenocorticotropin and cortisol in major depressive illness. Journal of Clinical Endocrinology and Metabolism, 61, 429–438.
Linnoila, M., Whorton, R., Rubinow, D. R., Cowdry, R. W., Ninan, P. T., & Waters, R. N. (1983). CSF prostaglandin levels in depressed and schizophrenic patients. Archives of General Psychiatry, 40, 405–406.
Linthorst, A. C. E., Flachskamm, G, Holsboer, F., & Reul, J. M. H. M. (1995a). Intraperitoneal administration of bacterial endotoxin enhances noradrenergic neurotransmission in the rat preoptic area: relationship with body temperature and hypothalamic-pituitary-adrenocortical axis activity. European Journal of Neuroscience, 7, 2418–2430.
Linthorst, A. C. E., Flachskamm, C, Muller-Preuss, P., Holsboer, F., & Reul, J. M. H. M. (1995b). Effect of bacterial endotoxin and interleukin-1 beta on hippocampal serotonergic neurotransmission, behavioral activity, and free corticosterone levels: an in vivo microdialysis study. Journal of Neuroscience, 15, 2920–2934.
Lycke, E., Norrby, R., & Roos, B. E. (1974). A serological study on mentally ill patients with particular reference to prevalence of herpes simplex virus infections. British Journal of Psychiatry, 124, 273.
Lyketsos, C. G., Steele, C, Baker, L., Galik, E., Kopunek, S., Steinberg, M., & Warren, A. (1997). Major and minor depression in Alzheimer’s disease: prevalence and impact. Journal of Neuropsychiatry and Clinical Neurosciences, 9(4), 556–561.
Lynch, E. A., Dinarello, C. A., & Cannon, J. G. (1994). Gender differences in IL-lα, IL-lβ, and IL-1 receptor antagonist secretion from mononuclear cells and urinary excretion. Journal of Immunology, 153, 300–306.
Maes, M. (1995). Evidence for an immune response in major depression: A review and hypothesis. Progress in Neuro-Psychopharmacology and Biological Psychiatry, 19, 11–38.
Maes, M., DeJonckheere, C, Vandervorst, C, Schotte, G, Cosyns, P., Raus, J., & Suy, E. (1991). Abnormal pituitary function during melancholia: Reduced alpha melanocyte stimulating hormone secretion and increased intact ACTH non-suppression. Journal of Affective Diseases, 22, 149–157.
Maes, M., Lambrechts, J., Bosmans, E., Jacobs, J., Suy, E., Vandervorst, G, De Jockheere, G, Minner, B., & Raus, J. (1992a). Evidence for systemic immune activation during depression: results of leukocyte enumeration by flow cytometry in conjunction with monoclonal antibody staining. Psychological Medicine, 22, 45–53.
Maes, M., Scharpe, S., Van Grootel, L., Uyttenbroeck, W., Cooreman, W., Cosyns, P., & Suy, E. (1992b). Higher alpha-1-antitrypsin, haptoglobin, ceruloplasmin, and lower retinol binding protein plasma levels during depression: further evidence for the existence of an inflammatory response during that illness. Journal of Affective Disorders, 24, 183–192.
Maes, M., Bosmans, E., Meltzer, H. Y., Scharpe, S., & Suy, E. (1993). Interleukin-lβ—A Putative Mediator of HPA Axis Hyperactivity in Major Depression. American Journal of Psychiatry, 150, 1189–1193.
Maes, M., Scharpe, S., Meltzer, H. Y., Okayli, G., D’Hondt, P., & Cosyns, P. (1994). Increased neopterin and interferon gamma secretion and lower L-tryptophan levels in major depression: further evidence for immune activation in severe depression. Psychiatry Research, 54, 143–160.
Maes, M., Meltzer, H. Y, Bosmans, E., Bergmans, R., Vandoolaeghe, E., Ranjan, R., & Desnyder, R. (1995a). Increased plasma concentrations of interleukin-6, soluble interleukin-6, soluble interleukin-2, and transferrin receptor in major depression. Journal of Affective Disorders, 34, 301–309.
Maes, M., Scharpe, S., Neels, H., Wauters, A., Van Gastel, A., & Cosyns, P. (1995b). Total serum protein and serum protein fractions in major depression. Journal of Affective Disorders, 34, 61–69.
Maes, M., Smith, R., & Scharpe, S. (1995c). The monocyte T-lymphocyte hypothesis of major depression. Psychoneuroendocrinology, 20, 111–116.
Maes, M., Bosmans, E., De Jongh, R., Kenis, G., Vandoolaeghe, E., & Neels, H. (1997a). Increased serum IL-6 and IL-1 receptor antagonist concentrations in major depression and treatment resistant depression. Cytokine, 9, 853–858.
Maes, M., Vandoolaeghe, E., Van Hunsel, F., Bril, T., Demedts, P., Wauters, A., & Neels, H. (1997b). Immune disturbances in treatment-resistant depression: modulation by antidepressive treatment. Human Psychopharmacology, 12, 153–162.
Magner, M. B. (1991). Psychiatric morbidity in outpatients with systemic lupus erythematosus. South African Medical Journal, 80, 291–293.
Maier, S. F. & Watkins, L. R. (1998). Cytokines for psychologists: Implications of bi-directional immune-to-brain communication for understanding behavior, mood, and cognition. Psychological Review, 105, 83–107.
Maj, M. (1996). Depressive syndromes and symptoms in subjects with human immunodefficiency virus (HIV) infection. British Journal of Psychiatry, 168, 117–122.
Marshal, P. S. (1993). Allergy and depression: A neurochemical threshold model of the relation between the illnesses. Psychological Bulletin, 113, 23–43.
Mathew, R. J. & Weinman, M. L. (1982). Sexual dysfunctions in depression. Archives of Sexual Behavior, 11, 323–328.
McDonald, E. M., Mann, A. H., & Thomas, H. G(1987). Interferons as mediators of psychiatric morbidity: An investigation in a trial of recombinant α-interferon in hepatitis-B carriers. Lancet, 2, 1175–1179.
McGeer, P. L. & McGeer, E. G. (1995). The inflammatory response system of brain: implications for therapy of Alzheimer and other neurodegenerative diseases. Brain Research Reviews, 21, 195–218.
Meijer, A., Zakay-Rones, Z., & Morag, A. (1988). Post-influenzal psychiatric disorder in adolescents. Acta Psychiatrica Scandinavica, 78, 176–181.
Mendez, M. F., Martin, R. J., Smyth, K. A., & Whitehouse, P. J. (1990). Psychiatric symptoms associated with Alzheimer’s disease. Journal of Neuropsychiatry and Clinical Neurosciences, 2(1), 28–33.
Meyers, G A. & Valentine, A. D. (1995). Neurologic and psychiatric adverse effects of immunological therapy. CNS Drugs, 3, 56–68.
Meyers, G A., Valentine, A. D., Wong, F. G L., & Leeds, N. E. (1994). Reversible neurotoxicity of interleukin-2 and tumor necrosis factor: Correlation of SPECT with neurophysiological testing. Journal of Neuropsychiatry and Clinical Neurosciences, 6, 285–288.
Meyerson, B. J. & Lindstrom, L. H. (1973). Sexual motivation in the female rat. Acta Physiologica Scandinavica, 389, 1–80.
Miller, N. E. (1964). Some psychophysiological studies of motivation and of the behavioral effects of illness. Bulletin of the British Psychological Society, 17, 1–20.
Miller, A. H., Asnis, G. M., Van Praag, H. M., & Norin, A. J. (1986). Influence of desmethylimipramine on natural killer cell activity. Psychiatry Research, 19, 9–15.
Minden, S. L. & Schiffer, R. B. (1990). Affective disorders in multiple sclerosis: Review and recommendations for clinical research. Archives of Neurology, 47, 98–104.
Minden, S. L., Orav, J., & Reich, P. (1987). Depression in multiple sclerosis. General Hospital Psychiatry, 9, 426–434.
Mohr, D. C., Goodkin, D. E., Likosky, W., Gatto, N., Baumann, K. A., & Rudick, R. A. (1997). Treatment of depression improves adherence to interferon β-Ib therapy for multiple sclerosis. Archives of Neurology, 54(5), 531–533.
Montgomery, S. A. (1994). Antidepressants in long-term treatment. Annual Review of Medicine, 45, 447–457.
Morag, M., Yirmiya, R., Lerer, B., & Morag, A. (in press). Influence of socioeconomic status on behavioral, emotional, and cognitive effects of rubella vaccination: A prospective, double blind sudy. Psychoneu-roendocrinology.
Mrak, R. E., Sheng, J. G., & Griffin, S. T. (1995). Glial cytokines in Alzheimer’s disease: review and pathogenic implications. Human Pathology, 26(8), 816–823.
Muller, N., Hofschuster, E., Ackenheil, M., Mempel, W., & Eckstein, R. (1993). Investigations of the cellular immunity during depression and the free interval: evidence for an immune activation in affective psychosis. Progress in Neuropsychopharmacology and Biological Psychiatry, 17, 713–730.
Murphy, J. M., Olivier, D. C., Monson, R. R., Sobol, A. M., Federman, E. B., & Leighton, A. H. (1991). Depression and anxiety in relation to social status. Archives of General Psychiatry, 48, 223–229.
Newman, M. E., Shapira, B., & Lerer, B. (1992). Regulation of 5-hydroxytryptamine 1A receptor function in rat hippocampus by short-and long-term administration of 5-hydroxytryptamine agonist and antidepressants. Journal of Pharmacology and Experimental Therapeutics, 260, 16–20.
Niiranen, A., Laaksonen, R., Iivanainen, M., Mattson, K., Fakkila, M., & Cantell, K. (1988). Behavioral assessment of patients treated with alpha-interferon. Acta Psychiatrica Scandinavica, 78, 622–626.
Oitzl, M. S., van Oers, H., Schobitz, B., & de Kloet, E. R. (1993). Interleukin-lβ, but not interleukin-6, impairs spatial navigation learning. Brain Research, 613, 160–163.
Okanoue, T., Sakamoto, S., Itoh, Y., Minami, M., Yasui, K., Sakamoto, M., Nishioji, K., Katagishi, T., Nakagawa, Y, Tada, H., Sawa, Y, Mizuno, M., Kagawa, K., & Kashima, K. (1996). Side effects of high-dose interferon therapy for chronic hepatitis C. Journal of Hepatology 25, 283–291.
Owens, M. J. & Nemeroff, C. B. (1993). The role of CRF in the pathophysiology of affective disorders: laboratory and clinical studies. In W. W. Vale (Ed.), Ciba Foundation Symposium on Corticotropin Releasing Factor, 172 (pp. 193–316). New York: John Wiley.
Parker, J., Smarr, K., Anderson, S., Hewett, J., Walker, S., Bridges, A., & Caldwell, W. (1992). Relationship of changes in helplessness and depression to disease activity in rheumatoid arthritis. Journal of Rheumatology, 19, 1901–1905.
Parry, B. L. (1995). Mood disorders linked to the reproductive cycle in women. In F. E. Bloom & D. J. Kupfer (Eds.), Psychopharmacology: The fourth Generation of Progress (pp. 1029–1042). New York: Raven Press.
Pavol, M. A., Meyers, C. A., Rexer, J. L., Valentine, A. D., Mattis, P. J., & Talpaz, M. (1995). Pattern of neurobehavioral deficits associated with interferon a therapy for leukemia. Neurology, 45, 947–950.
Pincus,, Griffith, J., Pearce, S., & Isenberg, D. (1996). Prevalence of self-reported depression in patients with rheumatoid arthritis. British Journal of Rheumatology, 35, 879–883.
Plata-Salaman, C. R. (1996). Anorexia during acute and chronic disease. Nutrition, 12, 69–78.
Plata-Salaman, C. R. (1998). Cytokines and anorexia: a brief overview. Seminars in Oncology, 25(1), 64–72.
Pollak, Y, Avitsur, R., Canaan, R., & Yirmiya, R. (1998). Central al adrenergic receptors are involved in mediating IL-1 induced sickness behavior. NeuroImmunoModulation, 5, 38.
Rabkin, J. G., Wagner, G., & Rabkin, R. (1994). Effects of setraline on mood and immune status in patients with major depression and HIV illness: an open trial. Journal of Clinical Psychiatry, 55, 433–439.
Ranchor, A. V., Bouma, J., & Sanderman, R. (1996). Vulnerability and social class: Differential patterns of personality and social support over the social classes. Personality and Individual Differences, 20(2), 229–237.
Renault, P. E, Hoofnagle, J. H., Park, Y, Mullen, K. D., Peters, M., Jones, D. B., Rustgi, V, & Jones, E. A. (1989). Psychiatric complications of long-term interferon alpha therapy. Archives of Internal Medicine, 147, 1577–1580.
Reul, J. M. H. M., Stec, I., Soder, M., & Holsboer, F. (1993). Chronic treatment of rats with antidepressant amitriptyline attenuates the activity of the hypothalamic-pituitary-adrenocortical system. Endocrinology, 133, 312–320.
Rivier, C. & Rivest, S. (1993). Mechanisms mediating the effects of cytokines on neuroendocrine functions in the rat. In D. J. Chadwick, J. Marsh, & K. Ackrill (Eds.), Corticotropin-Releasing Factor (pp. 204–225). New York: John Weily & Sons.
Robinson, R. G. (1997). Neuropsychiatric consequences of stroke. Annual Review of Medicine, 48, 217–229.
Rodin, G. & Voshart, K. (1986). Depression in the medically ill: An overview. American Journal of Psychiatry, 143, 696–705.
Romanovsky, A. A., Kulchitsky, V. A., Akulich, N. V., Koulchitsky, S. V., Simons, C. T., Sessler, D. I., & Gourine, V. N. (1996). First and second phases of biphasic fever: two sequential stages of the sickness syndrome. American Journal of Physiology, 271, R244–R253.
Rothwell, N. J., Luheshi, G., & Toulmond, S. (1996). Cytokines and their receptors in the central nervous system: Physiology, pharmacology, and pathology. Pharmacology and Therapeutics, 69, 85–95.
Sachar, E. J., Hellman, L., Fukushima, D. K., & Gallaghaer, T. F. (1970). Cortisol production in depressive illness: a clinical and biochemical clarification. Archives of General Psychiatry, 23, 289–298.
Sadovnick, A. D., Remick, R. A., Allen, I, Swartz, E., Lee, I. M. L., Eisen, K., Farquhar, R., Hashimoto, S. A., Hooge, I, Kastrukoff, L. F., Morrison, W., Nelson, J., Ogar, J., & Paty, D. W. (1996). Depression and multiple sclerosis. Neurology, 46, 628–632.
Sakic, B., Denburg, J. A., Denburg, S. D., & Szechtman, H. (1996). Blunted sensitivity to sucrose in autoimmune MRL-lpr mice: A curve shift study. Brain Research Bulletin, 41, 305–311.
Schiffer, R. B. & Babigian, H. M. (1984). Behavioral disorders in multiple sclerosis, temporal lobe epilepsy, and amyotrophic lateral sclerosis: An epidemiological study. Archives of Neurolology, 41, 1067–1069.
Schiffer, R. B. & Wineman, N. M. (1990). Antidepressant pharmacotherapy of depression associated with multiple sclerosis. American Journal of Psychiatry, 147, 1493–1497.
Schneebaom, A. B., Singleton, J. D., & West, S. G. (1991). Association of psychiatric manifestations with antibodies to ribosomal P proteins in systemic lupus erythematosus. American Journal of Medicine, 90, 54–62.
Schobitz, B., De Kloet, E. R., & Holsboer, F. (1994). Gene expression and function of interleukin 1, interleukin 6, and tumor necrosis factor in the brain. Progress in Neurobiology, 44, 391–432.
Schrott, L. M. & Crnic, L. S. (1996). Anxiety behavior, exploratory behavior, and activity in NZB X NZW Fl hybrid mice: role of genotype and autoimmune disease progression. Brain, Behavior, and Immunity, 10, 260–274.
Schubert, D. S. P. & Foliart, R. H. (1993). Increased depression in multiple sclerosis patients: A meta analysis. Psychosomatics, 34, 124–130.
Schwartz, J. A., Speed, N. M., Brunberg, J. A., Brewe, T. L., Brown, M., & Greden, J. F. (1993). Depression in stroke rehabilitation. Biological Psychiatry, 33, 694–699.
Scott, T. F., Nussbaum, P., McConnell, H., & Brill, P. (1995). Measurement of treatment response to sertraline in depressed multiple sclerosis patients using the Carroll scale. Neurological Research, 17, 421–422.
Segall, M. A. & Crnic, L. S (1990). An animal model for the behavioral effects of interferon. Behavioral Neuroscience, 4, 612–618.
Seidel, A., Arolt, V., Hunstiger, M., Rink, L., Behnisch, A., & Kirchner, H. (1995). Cytokine production and serum proteins in depression. Scandinavian Journal of Immunology, 41, 534–538.
Seidel, A., Arolt, V., Hunstiger, M., Rink, L., Behnisch, A., & Kirchner, H. (1996). Major depressive disorder is associated with elevated monocyte counts. Acta Psychiatrica Scandinavica, 94, 198–204.
Seilhean, D., Kobayashi, K., He, Y., Uchihara, T., Rosenblum, O., Katlama, C, Bricaire, F., Duyckaerts, C, & Hauw, J. J. (1997). Tumor necrosis factor-alpha, microglia, and astrocytes in AIDS dementia complex. Acta Neuropathologica, 93, 508–517.
Sluzewska, A., Rybakowski, J., Laciak, M., Mackiewicz, A., Sobieska, M., & Wiktorowicz, K. (1995). Interleukin-6 serum levels in depressed patients before and after treatment with fluoxetine. Annals of the New York Academy of Sciences, 762, 474–476.
Sluzewska, A., Rybakowski, J., Bosmans, E., Sobieska, M., Berghmans, R., Maes, M., & Wiktorowicz, K. (1996). Indicators of immune activation in major depression. Psychiatry Research, 64, 161–167.
Smith, B. K. & Kluger, M. J. (1993). Anti-TNF-alpha Antibodies Normalized Body Temperature and Enhanced Food Intake in Tumor-Bearing Rats. American Journal of Physiology, 265, R615–R619.
Smith, A. P., Tyrrell, D. A. J., Al-Nakib, W., Coyle, K. B., Donovan, C. B., Higgins, P. G., & Willman, J. S. (1987). Effects of experimentally induced respiratory virus infections and illness on psychomotor performance. Neurosychobiology, 18, 144–148.
Smith, A. P., Tyrrell, D. A. J., Al-Nakib, W., Coyle, K. B., Donovan, C. B., Higgins, P. G., & Willman, J. S. (1988). The effects of experimentally induced respiratory virus infections on performance. Psychological Medicine, 18, 65–71.
Smith, A. P., Tyrrell, D. A. J., & Barrow, G. I. (1992). Mood and experimentally induced respiratory virus infections and illness. Psychology and Health, 6, 205–212.
Smith, A. P., Thomas, M., Brockman, P., Kent, J., & Nicholson, K. G. (1993). Effect of Influenza B Virus Infection on Human Performance. British Medical Journal, 306, 760–761.
Sommer, N., Loschmann, P. A., Northoff, G. H., Weiler, M., Steinbrecher, A., Steinbach, J. P., Lichtenfels, R., Meyermann, R., Riethmuller, A., Fontana, A., Dichgans, J., & Martin, R. (1995). The antidepressant rolipram suppresses cytokine production and prevents autoimmune encephalomyelitis. Nature Medicine, 1, 244–248.
Song, C. & Leonard, B. E. (1994). An acute phase protein response in the olfactory bulbectomized rat: Effect of sertraline treatment. Medical Science Research, 22, 313–314.
Song, C, Dinan, T., & Leonard, B. E. (1994). Changes in immunoglobulin, complement and acute phase protein levels in depressed patients, and normal controls. Journal of Affective Disorders, 30, 283–288.
Sonti, G., Ilyin, S. E., & Plata-Salaman, C. R. (1996). Anorexia induced by cytokine interactions at pathophysiological concentrations. American Journal of Physiology, 270, R1394–R1402.
Spadaro, F. & Dunn, A. J. (1990). Intracerebroventricular administration of interleukin-1 to mice alters investigation of stimuli in a novel environment. Brain, Behavior, and Immunity, 4, 308–322.
Spriggs, D. R., Sherman, M. L., Michie, H., Arthur, K. A., Imamura, K., Wilmore, D, Frei, E., & Kufe, D. W. (1988). Recombinant human tumor necrosis factor administration as a 24-hr intravenous infusion. A phase I and pharmacologic study. Journal of National Cancer Institute, 80, 1039–1044.
Suzuki, T., Funada, M., Sugano, Y., Misawa, M., Okutomi, T., Soma, G. I., & Mizuno, D. (1994). Effects of a lipopolysaccharide from pantoea agglomerans on the cocaine-induced place preference. Life Sciences, 54, PL75–PL80.
Swiergiel, A. H., Smagin, G. N., & Dunn, A. J. (1996). Influenza virus infection of mice induces anorexia: Comparison with endotoxin and interleukin-1 and the effects of indomethacin. Pharmacology, Biochemistry, and Behavior, 57, 389–396.
Swiergiel, A. H., Smagin, G. N., Johnson, L. J., & Dunn, A. J. (1997). The role of cytokines in the behavioral responses to endotoxin and influenza virus infection in mice: effects of acute and chronic administration of the interleukin-1-receptor antagonist (IL-lra). Brain Research, 77, 696–104.
Takahashi, S., Kapas, L., Fang, J., Seyer, J. M., Wang, Y., & Krueger, J. M. (1996). An interleukin-1 receptor fragment inhibits spontaneous sleep and muramyl dipeptide-induced sleep in rabbits. American Journal of Physiology, 271, R101–R108.
Tilders, F. J. H., Derijk, R. H., Van Dam, A. M., Vincent, V. A. M., Schotanus, K., & Persoons, J. H. A. (1994). Activation of the Hypothalamus-Pituitary-Adrenal Axis by Bacterial Endotoxins—Routes and Intermediates. Psychoneuroendocrinology, 19, 209–232.
Traskman, L., Tybring, G., Asberg, M., Bertilsson, L., & Schalling, D. (1980). Cortisol in the CSF of depressed and suicidal patients. Archives of General Psychiatry, 37, 761–767.
Tueth, M. J. (1995). How to manage depression and psychosis in Alzheimer’s disease. Geriatrics, 50(1), 43–46, 49.
Turnbull, A. V. & Rivier, C. (1995). Regulation of the HPA axis by cytokines. Brain, Behavior, and Immunity, 9, 253–275.
Uehara, A., Sekiya, C, Takasugi, Y, Namiki, M., & Arimura, A. (1989). Anorexia induced by interleukin 1: involvement of corticotropin-releasing factor. American Journal of Phsyiology, 257, R613–R617.
Valentine, A. D., Meyers, C. A., Kling, M. A., Richelson, E., & Hauser, P. (1998). Mood and cognitive side effects in interferon-alpha therapy. Seminars in Oncology, 25(1), 39–47.
Van der Meer, M. J. M., Fred Sweep, C. G. J., Pesman, G. J., Borm, G. F, & Hermus, A. R. M. M. (1995). Synergism between IL-lβ and TNF-α on the activity of the pituitary-adrenal axis and on food intake in rats. American Journal of Physiology, 268, E551–E557.
Walker, L. G., Wesnes, K. P., Heys, S. D., Walker, M. B., Lolley, J., & Eremin, O. (1996). The cognitive effects of recombinant interleukin-2 (rIL-2) therapy: a controlled clinical trial using computerised assessments. European journal of Cancer, 13, 2275–2283.
Walker, L. G., Walker, M. B., Heys, S. D., Lolley, J., Wesnes, K. P., & Eremin, O. (1997). The psychological and psychiatric effects of rIL-2 therapy: a controlled clinical trial. Psychooncology, 6(4), 290–301.
Warren, E. J., Finck, B. N., Arkins, S., Kelley, K. W., Scamurra, R. W., Murtaugh, M. P., & Johnson, R. W. (1997). Coincidental changes in behavior and plasma cortisol in unrestrained pigs after intracerebroventricular injection of tumor necrosis factor-α. Endocrinology, 138, 2365–2371.
Watkins, L. R., Maier, S. F., & Goehler, L. E. (1995a). Cytokine-to-brain communication: A review and analysis of alternative mechanisms. Life Sciences, 57, 1011–1026.
Watkins, L. R., Maier, S. F., & Goehler, L. E. (1995b). Immune activation: the role of pro-inflammatory cytokines in inflammation, illness responses, and pathological pain states. Pain, 63, 289–302.
Weidenfeld, J. & Yirmiya, R. (1996). Effect of bacterial endotoxin on the glucocorticoid feedback regulation of adrenocortical response to stress, Neuroimmunomodulation, 3, 352–357.
Weizman, R., Laor, N., Podliszewski, E., Notti, I., Djaldetti, M., & Bessler, H. (1994). Cytokine Production in Major Depressed Patients Before and After Clomipramine Treatment. Biological Psychiatry, 35, 42–41.
Whitlock, F. A. & Siskind, M. M. (1980). Depression as a major symptom of multiple sclerosis. Journal of Neurology, Neurosurgery and Psychiatry, 43, 861–865.
Willner, P. (1994). Animal models of depression. In J. A. den Boer & J. M. Sitsen (Eds.), Handbook of depression and anxiety (pp. 291–316). New York: Marcel Dekker, Inc.
Willner, P. (1997). Validity, reliability, and utility of the chronic mild stress model of depression: A 10-year review and evaluation. Psychopharmacology, 134, 319–329.
Wilson, E. O. (1975). Sociobiology: The new synthesis. Cambridge: Harvard University Press.
Wohlman, A., Gallily, R., Yirmiya, R., & Weidenfeld, J. (1997). Characterization of the effect of Mycoplasma fermentans on the hypothalamo-pituitary-adrenal axis. Neuroendocrinology, 66, 221–228.
Wong, M. L., Bongiorno, P. B., Rettori, V., McCann, S. M., & Licinio, J. (1997). Interleukin (IL) Iβ, IL-1 receptor antagonist, IL-10, and IL-13 gene expression in the central nervous system and anterior pituitary during systemic inflammation: Pathophysiological implications. Proceedings of the National Academy of Sciences of the United States of America, 94, 227–232.
Xia, Z., DePierre, J. W., & Nassberger, L. (1996). Tricyclic antidepressants inhibit IL-6, IL-lβ, and TNF-α release in human blood monocytes and IL-2 and interferon-γ in T-cells. Immunobiology, 34, 27–37.
Xiao, L. & Eneroth, P. (1996). Tricyclic antidepressants inhibit human natural killer cells. Toxicology and Applied Pharmacology, 137, 157–162.
Yamada, T. & Yamanaka, I. (1995). Microglial localization of alpha interferon receptor in human brain tissues. Neuroscience Letters, 189, 73–76.
Yehuda, R. & Nemeroff, C. B. (1994). Neuropeptide alterations in affective and anxiety disorders. In J. A. den Boer & J. M. Sitsen (Eds.), Handbook of depression and anxiaty (pp. 543–571). New York: Marcel Dekker, Inc.
Yirmiya R. (1996). Endotoxin produces a depressive-like syndrome in rats. Brain Research, 711, 163–174.
Yirmiya, R. (1997). Behavioral and psychological effects of immune activation: Implications for “depression due to a general medical condition”. Current Opinion in Psychiatry, 10, 470–476.
Yirmiya, R., Rosen, H., Donchin, O., & Ovadia, H. (1994). Behavioral effects of lipopolysaccharide in rats: Involvement of endogenous opioids. Brain Research, 648, 80–86.
Yirmiya, R., Avitsur, R., Donchin, O., & Cohen, E. (1995). Interleukin-1 inhibits sexual behavior in female but not in male rats. Brain, Behavior, and Immunity, 9, 220–33.
Yirmiya, R., Barak, O., Avitsur, R., Gallily, R., & Weidenfeld, J. (1997). Intracerebral administration of Mycoplsma fermentans produces sickness behavior: role of prostaglandins. Brain Research, 749, 71–81.
Zacharko, R. M., Zalcman, S., Macneil, G., Andrews, M., Mendella, P. D., & Anisman, H. (1997). Differential effects of immunologic challenge on self-stimulation from the nucleus accumbens and the substantia nigra. Pharmacology, Biochemistry, and Behavior, 58, 881–886.
Zhu, J., Bengtsson, B. O., Mix, E., Thorell, L. H., Olsson, T., & Link, H. (1994). Effect of monoamine reup-take inhibiting antidepressants on major histocompatibility complex expression on macrophages in normal rats and rats with experimental allergic neuritis (EAN). lmmunopharmacology, 27(3), 225–244.
Zorzenon, M., Colle, R., Vecchio, D., Bertoli, M., Giavedoni, A., Degrassi, A., Lavaroni, S., & Aguglia, E. (1996). Major depression, viral reactivation, and immune system. European Psychiatry, 11, 332.
Zubareva, O. E., Abdurasulova, I. N., Bluthe, R. M., Dantzer, R., & Klimenko, V. M. (1998). Effects of serotonin synthesis blockade on IL-1 beta actions in the brain of rats. NeuroImmunoModulation, 5, 56.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1999 Kluwer Academic/Plenum Publishers
About this chapter
Cite this chapter
Yirmiya, R. et al. (1999). Cytokines, “Depression Due to A General Medical Condition,” and Antidepressant Drugs. In: Dantzer, R., Wollman, E.E., Yirmiya, R. (eds) Cytokines, Stress, and Depression. Advances in Experimental Medicine and Biology, vol 461. Springer, New York, NY. https://doi.org/10.1007/978-0-585-37970-8_16
Download citation
DOI: https://doi.org/10.1007/978-0-585-37970-8_16
Published:
Publisher Name: Springer, New York, NY
Print ISBN: 978-0-306-46135-4
Online ISBN: 978-0-585-37970-8
eBook Packages: Springer Book Archive